$942 Million is the total value of SECTORAL ASSET MANAGEMENT INC's 168 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 20.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| TDOC | Sell | TELADOC HEALTH | $26,926,000 | -1.9% | 311,821 | -34.1% | 2.86% | -6.9% |
| KTWO | Sell | K2M GROUP HOLDINGS | $24,818,000 | +16.0% | 906,741 | -4.6% | 2.64% | +10.2% |
| EXAS | Sell | EXACT SCIENCES CORP | $20,602,000 | -28.0% | 261,050 | -45.5% | 2.19% | -31.7% |
| PFE | Sell | PFIZER INC | $19,828,000 | +11.5% | 449,926 | -8.2% | 2.10% | +5.8% |
| PTLA | Sell | PORTOLA PHARMACEUTICALS | $19,829,000 | -34.0% | 744,607 | -6.4% | 2.10% | -37.3% |
| JNJ | Sell | JOHNSON & JOHNSON | $19,244,000 | +13.1% | 139,280 | -0.6% | 2.04% | +7.4% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL | $17,910,000 | -27.0% | 184,695 | -29.1% | 1.90% | -30.7% |
| XLRN | Sell | ACCELERON PHARMA | $17,096,000 | +14.9% | 298,726 | -2.6% | 1.82% | +9.1% |
| UNH | Sell | UNITEDHEALTH GRP INC | $15,378,000 | +1.5% | 57,805 | -6.4% | 1.63% | -3.6% |
| ABMD | Sell | ABIOMED INC | $12,893,000 | -30.4% | 28,668 | -36.7% | 1.37% | -33.9% |
| MDT | Sell | MEDTRONIC PLC | $12,872,000 | +1.7% | 130,851 | -11.5% | 1.37% | -3.4% |
| ALXN | Sell | ALEXION PHARM INC | $12,288,000 | -45.1% | 88,399 | -51.0% | 1.30% | -47.9% |
| UMRX | Sell | UNUM THERAPEUTICS | $10,783,000 | -30.5% | 1,046,945 | -3.2% | 1.14% | -34.0% |
| ALDR | Sell | ALDER BIOPHARMACEUTICALS | $10,150,000 | -38.2% | 609,612 | -41.3% | 1.08% | -41.3% |
| LLY | Sell | ELI LILLY & CO | $5,984,000 | -42.8% | 55,766 | -54.5% | 0.64% | -45.7% |
| MDGL | Sell | MADRIGAL PHARMACEUTICALS | $5,543,000 | -48.1% | 25,887 | -32.1% | 0.59% | -50.7% |
| EVLO | Sell | EVELO BIOSCIENCES | $4,959,000 | -4.0% | 407,171 | -6.9% | 0.53% | -8.8% |
| MASI | Sell | MASIMO CORP | $4,372,000 | +6.1% | 35,102 | -16.8% | 0.46% | +0.7% |
| SRPT | Sell | SAREPTA THERAPEUTICS | $4,361,000 | -84.0% | 27,000 | -86.9% | 0.46% | -84.8% |
| ESPR | Sell | ESPERION THERAPEUTICS | $4,264,000 | -48.3% | 96,100 | -54.3% | 0.45% | -50.9% |
| ZLAB | Sell | ZAI LAB LTDadr | $876,000 | -22.6% | 44,968 | -7.6% | 0.09% | -26.8% |
| INCY | Sell | INCYTE CORPORATION | $768,000 | -85.5% | 11,113 | -86.0% | 0.08% | -86.2% |
| SHPG | Sell | SHIRE PLCsp adr | $236,000 | -68.9% | 1,300 | -71.1% | 0.02% | -70.6% |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -34,100 | -100.0% | -0.27% | – |
| RCKT | Exit | ROCKET PHARMACEUTICA | $0 | – | -237,158 | -100.0% | -0.52% | – |
| EW | Exit | EDWARDS LIFESCIENCE | $0 | – | -40,860 | -100.0% | -0.66% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -84,000 | -100.0% | -0.75% | – |
| PRAH | Exit | PRA HEALTH SCIENCE | $0 | – | -148,560 | -100.0% | -1.55% | – |
| MOH | Exit | MOLINA HEALTHCARE | $0 | – | -178,870 | -100.0% | -1.96% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 45 | Q2 2024 | 6.7% |
| DR REDDYS LABS LTD | 45 | Q2 2024 | 2.0% |
| PTC THERAPEUTICS INC | 43 | Q2 2024 | 2.7% |
| GILEAD SCIENCES INC | 41 | Q2 2024 | 8.4% |
| VERTEX PHARMACEUTICL | 41 | Q2 2024 | 6.0% |
| INCYTE CORPORATION | 41 | Q2 2024 | 5.2% |
| AMICUS THERAPEUTICS INC | 40 | Q2 2024 | 6.6% |
| PFIZER INC | 38 | Q2 2024 | 6.3% |
| MERCK & CO. INC | 37 | Q2 2024 | 6.4% |
| MEDTRONIC PLC | 36 | Q2 2024 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| eFFECTOR Therapeutics, Inc. | February 14, 2024 | 2,382,644 | 3.7% |
| Galera Therapeutics, Inc.Sold out | February 14, 2024 | 0 | 0.0% |
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-13 |
| N-PX | 2024-08-09 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.